We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCM
476
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.67M | 0.04% |
194,383
+32,546
| +20% | +$647K |
|
477
NetApp
NTAP
$40.2B
| $4.67M | 0.04% |
70,452
+55,240
| +363% | +$2.92M |
|
|
GTHX
478
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $4.66M | 0.04% |
258,777
+239,423
| +1,237% | +$3.58M |
|
|
VRTU
479
DELISTED
Virtusa Corporation
VRTU
| $4.61M | 0.04% |
90,249
+8,195
| +10% | +$412K |
|
480
Olin
OLN
$2.17B
| $4.59M | 0.04% |
186,814
+78,459
| +72% | +$1.6M |
|
481
NVR
NVR
$17B
| $4.58M | 0.04% |
1,122
+845
| +305% | +$3.51M |
|
482
Clean Harbors
CLH
$16.9B
| $4.58M | 0.04% |
60,132
+16,712
| +38% | +$1.12M |
|
483
Ingersoll Rand
IR
$32.7B
| $4.54M | 0.04% |
99,700
-30,680
| -24% | -$1.27M |
|
484
Acadia Healthcare
ACHC
$2.82B
| $4.52M | 0.04% |
+89,949
| New | +$3.59M |
|
485
PetMed Express
PETS
$43.4M
| $4.5M | 0.04% |
140,329
-43,442
| -24% | -$1.34M |
|
486
Skywest
SKYW
$4.21B
| $4.48M | 0.04% |
111,168
-26,480
| -19% | -$967K |
|
487
CRISPR Therapeutics
CRSP
$5.22B
| $4.47M | 0.04% |
+29,191
| New | +$3.45M |
|
488
Coeur Mining
CDE
$19B
| $4.46M | 0.04% |
431,210
+344,267
| +396% | +$2.83M |
|
489
The Ensign Group
ENSG
$10.6B
| $4.45M | 0.04% |
61,040
-2,430
| -4% | -$161K |
|
490
NiSource
NI
$20.2B
| $4.45M | 0.04% |
193,941
+31,484
| +19% | +$736K |
|
491
Public Service Enterprise Group
PEG
$37.8B
| $4.44M | 0.04% |
+76,175
| New | +$4.44M |
|
492
Baker Hughes
BKR
$63B
| $4.43M | 0.04% |
+212,465
| New | +$3.73M |
|
493
Nektar Therapeutics
NKTR
$2.57B
| $4.35M | 0.04% |
17,042
+5,386
| +46% | +$1.39M |
|
494
Nomad Foods
NOMD
$1.68B
| $4.35M | 0.04% |
170,955
+118,636
| +227% | +$2.94M |
|
495
Freedom Holding
FRHC
$9.35B
| $4.33M | 0.04% |
+84,340
| New | +$2.96M |
|
|
COOP
496
DELISTED
Mr. Cooper
COOP
| $4.32M | 0.04% |
139,272
+24,168
| +21% | +$619K |
|
497
Guardant Health
GH
$21.4B
| $4.29M | 0.04% |
+33,269
| New | +$3.83M |
|
498
AMC Global Media
AMCX
$496M
| $4.24M | 0.04% |
118,644
-191,527
| -62% | -$5.36M |
|
499
Unum
UNM
$14.7B
| $4.24M | 0.04% |
+184,932
| New | +$3.82M |
|
500
Alamos Gold
AGI
$13.8B
| $4.21M | 0.04% |
480,812
-472,176
| -50% | -$4.19M |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.